Acasti Pharma, Inc. (ACST) Financials

Stock symbol ACST is outdated, potentially delisted? Maybe it is available on other exchange?

ACST Assets vs Liabilities

Date	Assets	Liabilities
Dec. 31, 2023	57.4 million	8.7 million
Sept. 30, 2023	57.5 million	8.4 million
June 30, 2023	55.2 million	6.8 million
March 31, 2023	58.5 million	8.3 million

ACST Free Cash Flow and Stock based compensation

Graph available only for paid members. Upgrade to see it.

Date	Free Cash Flow	Stock based compensation
Dec. 31, 2023	-1.4 million	245787
Sept. 30, 2023	-1.6 million	206026
June 30, 2023	-4.7 million	58921
March 31, 2023	-2.5 million	238005

ACST Net Income

No data available :(

ACST Cash and Debt

Graph available only for paid members. Upgrade to see it.

Date	Cash	Debt	Capital Lease
Dec. 31, 2023	18.9 million	-	18094
Sept. 30, 2023	19.9 million	-	33847
June 30, 2023	16.4 million	-	60431
March 31, 2023	20.6 million	-	358485

ACST Shares Outstanding

Graph available only for paid members. Upgrade to see it.

Date	Shares Outstanding
Dec. 31, 2023	8.7 million
Sept. 30, 2023	5.6 million
June 30, 2023	5.6 million
March 31, 2023	5.5 million

ACST Expenses

Graph available only for paid members. Upgrade to see it.

Date	Capex	R&D	G&A	S&M
Dec. 31, 2023	-	1.1 million	1.2 million	22618
Sept. 30, 2023	-	338471	1.2 million	31639
June 30, 2023	-	827162	1.4 million	45323
March 31, 2023	5913	1.2 million	1.8 million	37696

ACST Cost of Revenue

Graph available only for paid members. Upgrade to see it.

Date	Revenue	Cost of Revenue
Dec. 31, 2023	-	2.3 million
Sept. 30, 2023	-	1.5 million
June 30, 2023	-	3.4 million
March 31, 2023	-23652	10.4 million

ACST

Price: $3.37

52 week price:

1.98

3.60

Earnings Per Share: -1.43 USD

P/E Ratio: -0.41

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Country: Canada

Volume: 172300

Ebitda: -8.8 million

Market Capitalization: 33.2 million

Links:

ACST on Yahoo Finance